Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Marijuana Abuse 2Breast Neoplasms 2Anxiety Disorders 2Sturge-Weber Syndrome 1Solid Tumor 1Prostatic Neoplasms 1Parasomnias 1Pain 1Nausea 1Glioblastoma 1Colonic Neoplasms 1Cognitive Dysfunction 1Chemotherapy-Induced Peripheral Neuropathy 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Cancer Pain 1Breast Carcinoma In Situ 1Arthralgia 1

Interventions

Therapeutics 1Testosterone 1Surveys and Questionnaires 1Letrozole 1Hyaluronic Acid 1Glucosamine 1Glucaric Acid 1Chondroitin Sulfates 1Chondroitin 1Cholecalciferol 1Cannabidiol 1Calcium Gluconate 1Calcium Citrate 1Calcium Carbonate 1Calcium 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Arthralgia × Cannabidiol × Clear all
NCT04754399 2025-05-09

Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

University of Michigan Rogel Cancer Center

Phase 2 Completed
40 enrolled 10 charts
Breast

Breast Neoplasms, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡